Cancer Biology [CAB], Neuroscience [NEU]
PHD, University of Connecticut
BA, State University of New York at Binghamton
PhD, University of Connecticut
, Columbia Univeristy
, Memorial Sloan-Kettering Cancer Center (MSKCC)
Internship, Clinical Psychology
Manhattan Veterans Administration Medical Center
Hypnosis to reduce aromatase inhibitor (AI)-associated musculoskeletal pain (MSP) and to improve AI adherence: An RCT to explore clinical efficacy and cost effects
National Institute of Health
The overall goal of the project is to test the clinical efficacy and cost effectiveness of hypnosis to reduce musculoskeletal pain and improve AI adherence in breast cancer patients.
Cancer treatment retraumatization in sexual abuse survivors
National Cancer Institute
The overall goal of the project is to develop a greater understanding of SACA patients experiences of cancer treatment, how this suffering relates to treatment avoidance, and which SACA patients are most at risk for cancer treatment retraumatization and avoidance.
E-Counseling in psychosocial cancer care: A competency-based E-Learning approach
National Cancer Institute
The goal of this project is to train (using an E-Learning approach) psychosocial cancer care providers in the foundational competencies of E-Counseling for cancer.
Cancer Prevention & Control: Multidisciplinary Training
National Cancer Institute
The goal is to enable trainees and junior faculty to become independent researchers and mentors in cancer prevention and control.
Dr. Montgomery’s research focuses on developing, testing and disseminating psychological and integrative interventions to reduce suffering related to cancer and its treatment. Critical findings are: 1) Through an RCT of breast conserving surgery patients, he and his group found that patients who received a brief presurgery hypnosis intervention needed less propofol and lidocaine; reported less pain intensity, pain unpleasantness, nausea, fatigue, discomfort, and emotional upset; and, cost the institution $772.71 less per patient than patients in an attention control group. 2) In an RCT of breast cancer radiotherapy patients, he found that that a brief intervention including cognitive-behavioral therapy plus hypnosis (CBTH) reduced fatigue in patients during radiotherapy, and for up to six months following radiotherapy. Results support CBTH as a highly effective means for controlling and potentially preventing fatigue in breast cancer radiotherapy patients. 3) Throughout his program of research, Dr. Montgomery has demonstrated that response expectancies and emotional distress play important roles in the development of cancer patients’ treatment-related side effects (e.g., chemotherapy-related nausea, postsurgical quality of life). 4) Dr. Montgomery is presently working on developing and testing E-Learning training programs to teach psychosocial cancer care providers in the use of E-Counseling with cancer patients and survivors. 5) Dr. Montgomery was recently funded to study the role of hypnosis in reducing musculoskeletal pain and improving medication adherence in breast cancer survivors prescribed aromatase inhibitors. Overall, Dr. Montgomery’s program of research focuses on examining, with scientific rigor, the effects of behavioral medicine and integrative interventions on the lives of cancer patients. Scientific inquiry will permit a culling out of efficacious applications. Perhaps most importantly however, the research findings ensuing from this program (and dissemination of the approaches discovered therein) may lead to sweeping changes in the treatment and care of cancer patients, and as a consequence, to major improvements in their quality of life.
Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, Hallquist MN, Schnur JB. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. Journal of Clinical Oncology 2014 Feb; 32(6): 557-563.
Montgomery GH, Schnur JB, Kravits K. Hypnosis for cancer care: over 200 years young. CA: A Cancer Journal for Clinicians 2013 Jan; 63(1): 31-44.
Montgomery GH, Kirsch I. Classical conditioning and the placebo effect. Pain 1997 Aug; 72(1-2): 107-113.
Montgomery GH, Weltz CR, Seltz M, Bovbjerg DH. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002 Jan; 50(1): 17-32.
Kangas M, Montgomery GH. The role of cognitive, emotional and personality factors in the experience of fatigue in a university and community sample. Psychology & Health 2011 May; 26 Suppl 1: 1-19.
Montgomery GH, Hallquist MN, Schnur JB, David D, Silverstein JH, Bovbjerg DH. Mediators of a brief hypnosis intervention to control side effects in breast surgery patients: response expectancies and emotional distress. Journal of Consulting and Clinical Psychology 2010 Feb; 78(1): 80-88.
Montgomery GH, David D, Winkel G, Silverstein JH, Bovbjerg DH. The effectiveness of adjunctive hypnosis with surgical patients: A meta-analysis. Anesth Analg 2002 June; 94(6): 1639-1645.
Montgomery GH, Schnur JB, Erblich J, Diefenbach MA, Bovbjerg DH. Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery. Journal of Pain and Symptom Management 2010 Jun; 39(6): 1043-1052.
Montgomery GH, Bovbjerg DH. Expectations of chemotherapy-related nausea: Emotional and experiential predictors. Ann Behav Med 2003; 25(1): 48-54.
Montgomery GH, Bovbjerg DH. Presurgery distress and specific response expectancies predict postsurgery outcomes in surgery patients confronting breast cancer. Health Psychol 2004 Jul; 23(4): 381-387.
Montgomery GH, Kangas M, David D, Hallquist MN, Green S, Bovbjerg DH, Schnur JB. Fatigue during breast cancer radiotherapy: an initial randomized study of cognitive-behavioral therapy plus hypnosis. Health Psychology 2009 May; 28(3): 317-322.
Green JP, Barabasz AF, Barrett D, Montgomery GH. Forging ahead: the 2003 APA Division 30 definition of hypnosis. Int J Clin Exp Hypn 2005 Jul; 53(3): 259-264.
Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychological Bulletin 2008 Sep; 134(5).
David D, Bovbjerg DH, Montgomery GH. Relations between coping responses and optimism?"pessimism in predicting anticipatory psychological distress in surgical breast cancer patients. Personality and Individual Differences 2006 Jan; 40(2): 203-213.
Montgomery GH, Bovbjerg DH, Schnur JB, David D, Goldfarb A, Weltz CR, Schechter C, Graff-Zivin J, Tatrow K, Price DD, Silverstein JH. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. Journal of the National Cancer Institute 2007 Sep; 99(17): 1304-1312.
Montgomery GH, Bovbjerg DH. Presurgery distress and specific response expectancies predict postsurgery outcomes in surgery patients confronting breast cancer. Health Psychology 2004 Jul; 23(4): 381-387.
Montgomery GH, David D, Dilorenzo T, Erblich J. Is hoping the same as expecting? Discrimination between hopes and response expectancies for nonvolitional outcomes. Personality and Individual Differences 2003; 35(2): 399-409.
Montgomery GH, David D, Winkel G, Silverstein JH, Bovbjerg DH. The effectiveness of adjunctive hypnosis with surgical patients: a meta-analysis. Anesthesia and Analgesia 2002 Jun; 94(6): 1639-1645.
Montgomery GH, Bovbjerg DH. Specific response expectancies predict anticipatory nausea during chemotherapy for breast cancer. Journal of Consulting and Clinical Psychology 2001 Oct; 69(5): 831-835.
Montgomery GH, DuHamel KN, Redd WH. A meta-analysis of hypnotically induced analgesia: how effective is hypnosis?. The International Journal of Clinical and Experimental Hypnosis 2000 Apr; 48(2): 138-153.
Montgomery GH, Bovbjerg DH. The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer. Physiology & Behavior 1997 May; 61(5): 737-741.
Montgomery GH, Kirsch I. Mechanisms of placebo pain reduction: An empirical investigation. Psychological Science 1996 May; 7(3): 174-176.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Montgomery did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.